CICIC DRAGAN
SEC insider (Form 3/4/5 filer). CIK 0001565795. SVP, Chief Development Officer at SELLAS Life Sciences Group, Inc. (SLS). 5 reported Form 4/5 transactions since Sep 2024; latest on Jan 7, 2026. Located in NEW YORK, NY.
Companies CICIC DRAGAN has filed insider reports for
- SELLAS Life Sciences Group, Inc. (SLS): Officer, SVP, Chief Development Officer
CICIC DRAGAN
CIK: 0001565795
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SELLAS Life Sciences Group, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jan 7, 2026SLS
SELLAS Life Sciences Group, Inc.
AwardDirect300K shares- - Dec 3, 2025SLS
SELLAS Life Sciences Group, Inc.
OtherDirect63.8K shares at avg. $1.50$96K - Jan 10, 2025SLS
SELLAS Life Sciences Group, Inc.
AwardDirect113K shares- - Jan 10, 2025SLS
SELLAS Life Sciences Group, Inc.
AwardDirect81.3K shares- - Dec 4, 2024SLS
SELLAS Life Sciences Group, Inc.
OtherDirect8.3K shares at avg. $1.13$9K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 7, 2026 | SLS SELLAS Life Sciences Group, Inc. | Award | 300,000 | - | $0 | Direct |
| Dec 3, 2025 | SLS SELLAS Life Sciences Group, Inc. | Other | 63,800 | $1.50 | $95,700 | Direct |
| Jan 10, 2025 | SLS SELLAS Life Sciences Group, Inc. | Award | 113,000 | - | $0 | Direct |
| Jan 10, 2025 | SLS SELLAS Life Sciences Group, Inc. | Award | 81,300 | - | $0 | Direct |
| Dec 4, 2024 | SLS SELLAS Life Sciences Group, Inc. | Other | 8,256 | $1.13 | $9,329 | Direct |
1-5 of 5 transactions